Abortion considerations when no yolk sac is detected

March 5, 2026

By Siripanth Nippita, MD, MS and Maureen Paul, MD, MPH

Many people know they’re pregnant early. For some, if a pregnancy is unwanted, they seek abortion care right away. But what if I don’t see a gestational sac with a yolk sac on an ultrasound?

Drs. Siripanth Nippita and Maureen Paul respond: You can still provide abortion care! It is still important to consider the risk of ectopic pregnancy (EP), though this risk is lower among
individuals seeking abortion compared with the general population.

If a transvaginal ultrasound does not demonstrate an intrauterine or extrauterine pregnancy, and the pregnancy test is positive, this is a pregnancy of unknown location (PUL).

If you see a gestational sac (round or oval, with a hyperechoic rim) without a yolk sac or any type of fluid collection in the uterus, this is a probable intrauterine pregnancy, and the risk of EP is much lower.

Question: Can I provide mifepristone and misoprostol in these situations?

Answer: Yes, after assessing risk for ectopic pregnancy!

It is safe to start medication management for a patient with PUL or a probable intrauterine pregnancy after assessing an individual’s risk of EP based on risk factors and current symptoms. You do not have to wait to see a definite intrauterine pregnancy (gestational sac with a yolk sac, implanted in a normal location) to initiate treatment.

You should also give ectopic pregnancy precautions to all patients choosing immediate treatment.

Question: How do I make sure the medication worked?

Answer: Serum hCG follow-up is recommended for individuals with PUL. You should get a baseline hCG level at the initial visit. Schedule a follow-up hCG either 48-72 hours after misoprostol (which should drop by at least 50%) or if not feasible, 5-10 days after misoprostol (which should drop by at least 80%).

Individuals with a probable intrauterine pregnancy can also have hCG follow up to confirm pregnancy resolution. If this is not possible, use an alternative approach such as a home urine pregnancy test 14 days after mifepristone.

Question: What if the patient wants a procedure?

Answer: Procedural management with confirmation of pregnancy resolution is safe for individuals with PUL or probable IUP. If you see both a gestational sac and villi (which is not expected in individuals with PUL), no further follow-up is needed. If no sac is seen, draw a serum hCG on the day of procedure with a plan to repeat it in 24-72 hours. Levels should drop by at least 50% after 24 hours, 70% after 48 hours, and 80% after 72 hours.

Want more?

Read more about early and medication abortion in the authors’ chapter on Abortion in Contraceptive Technology, 22nd edition.

Other Latebreakers

Mar. 05, 2026

Abortion considerations when no yolk sac is detected

Jan. 08, 2026

There’s no possible way I could be pregnant!

Nov. 01, 2025

Answering your questions about wellness exams for adults assigned female at birth – often called the “well woman exam”

Sep. 05, 2025

Acute Heavy Menstrual Bleeding!

Aug. 01, 2025

New and Updated Guidelines for Cervical Cancer Screening

Jun. 20, 2025

The Patient Asks—I’m on Depo-Provera, What’s My Risk for Meningioma?

May. 01, 2025

Clinical Tools for Contraceptive Eligibility and Practice

Jan. 13, 2025

New ovarian cyst despite CHC use by patient with PCOs?

Nov. 14, 2024

Mood Swings, Depression, and CHCs

Oct. 15, 2024

Higher Body Weight Effect on Combined Hormonal Contraceptives

Sep. 09, 2024

Perimenopause: pregnancy risks

Aug. 13, 2024

NEW! 2024 MEC & SPR (Free from the CDC)

Jul. 19, 2024

Medication Interactions and Contraceptive Effectiveness

Jun. 05, 2024

“Birth control has a TikTok problem.”

May. 08, 2024

Implant: Unpredictable Bleeding and Management

Mar. 19, 2024

Weight Changes and hormonal contraceptives

Feb. 16, 2024

What most affects contraceptive continuation?

Jan. 03, 2024

Resuming CT monthly updates! Introducing the new edition of Contraceptive Technology

Dec. 20, 2021

Substance use disorder: contraceptive options counseling

Oct. 15, 2021

What’s New in Contraception?

Sep. 21, 2021

Contraceptive Technology Conference!

Aug. 25, 2021

Biologic sexism of STIs

Jul. 16, 2021

Excess breast cancer deaths after COVID-19

Jul. 04, 2021

Contraception for patients with medical conditions

May. 18, 2021

Pelvic Floor Dysfunction

Mar. 04, 2021

Treating vulvodynia

Feb. 11, 2021

Puzzling Over the Hurt Down-Under

Jan. 06, 2021

Serious Mental Illness and Contraception

Oct. 28, 2020

New 13-Cycle Vaginal Contraceptive System

Oct. 08, 2020

The Future of Family Planning in Post-COVID America

Sep. 09, 2020

New ASCCP Guidelines: Implications for FP

Aug. 02, 2020

On the alert: mood disorders during 2020 stressors

Jun. 25, 2020

Sex in the Time of COVID-19

May. 08, 2020

Challenges old and new during the pandemic

Mar. 31, 2020

Reproductive health in the time of Covid-19

Mar. 09, 2020

Talking about toys

Feb. 10, 2020

Missed Pills: The Problem That Hasn’t Gone Away

Jan. 02, 2020

Find the “yes! . . . and” rather than “no” or “but”

Nov. 01, 2019

Digital Family Planning: the Future is Now

Oct. 08, 2019

Irregular Bleeding Due to Contraceptives

Sep. 06, 2019

When she’s low on libido…

Aug. 06, 2019

Ouch! Best approaches to menstrual pain

Jun. 27, 2019

Contraceptive efficacy: understanding how user and method characteristics play their part

May. 29, 2019

Strategizing treatment for chronic heavy menstrual bleeding

May. 10, 2019

Perimenopause

Mar. 27, 2019

Untangling the literature on obesity and contraception

Feb. 26, 2019

High tech apps for no-tech FABM

Jan. 25, 2019

Menstrual exacerbation of other medical conditions

Jan. 04, 2019

From Princeton University: Thomas James Trussell (1949-2018)

Nov. 30, 2018

The Short and Long of IUD Use Duration

Oct. 30, 2018

Selecting a Method When Guidance Isn’t Clear-cut

Oct. 04, 2018

Healthcare in the Time of Digital Expansion

Aug. 30, 2018

Combined pills’ effect on mood disorders

Aug. 30, 2018

The Scoop on Two New FDA-Approved Contraceptive Methods

Aug. 01, 2018

Pregnancy of unknown location—meeting the challenge

Jul. 03, 2018

Big “yes” (with caveats) to CHCs during perimenopause

Apr. 02, 2018

Abortion in the U.S.: safe, declining, and under threat

Feb. 02, 2018

Hope for ovarian cancer screening test

Jan. 03, 2018

Breast cancer still a small risk with some hormonal contraceptives

Dec. 04, 2017

New treatment modality for BV

Nov. 07, 2017

Record rate of HPV-related throat cancer

Oct. 03, 2017

Viruses in semen potentially transmissible

Sep. 01, 2017

Don’t Abstain from Your Role in Abstinence

Jul. 26, 2017

Teens births declining but geographic ‘hotspots’ defy trend

Jun. 27, 2017

Online Medical Abortion Service Effective and Safe

May. 30, 2017

Do Women Really Need to Wait That Long?

May. 05, 2017

Reassuring news on depression and OC use

Apr. 06, 2017

PMDD: Genetic clues may lead to improved treatment

Mar. 02, 2017

Breast cancer risk when there is a family history

Feb. 03, 2017

Body weight link to breast and endometrial cancers (and 11 others)

Jan. 03, 2017

Family Planning in 2017 and Beyond

Dec. 01, 2016

Make Me Cry: Depression Link (Again)?

Nov. 02, 2016

Managing implant users’ bleeding and spotting

Oct. 13, 2016

Zika: Updated guidance for providers

Sep. 06, 2016

Pharmacist-prescribed contraceptives

Aug. 01, 2016

Hot off the press! 2016 MEC and SPR

Jul. 05, 2016

Zika virus fears prompt increased request for abortion in nations outlawing abortions

Jun. 13, 2016

Opioid use epidemic among reproductive-age women

May. 04, 2016

Good news on the family planning home front!

Apr. 04, 2016

War Against Planned Parenthood Hurts Women

Feb. 16, 2016

Win-win for both treatment and prevention

Feb. 08, 2016

Center of the Storm

Dec. 01, 2015

Ambivalence

Nov. 02, 2015

Menopause, mood, mental acuity, and hormone therapy

Oct. 01, 2015

Emergency contraception for teens

Sep. 03, 2015

Postpartum Contraception: Now, Not Later

Aug. 03, 2015

Reproductive tract infections, sexually transmitted infections, or sexually transmitted diseases: “a rose by any other name…”

Jun. 25, 2015

Are we practicing what we preach?

Jun. 02, 2015

Be alert to VTE in hormonal contraceptive users

May. 04, 2015

LARC among teens increased 15-fold, but not enough

Mar. 30, 2015

Brain cancer and hormonal contraception

Mar. 02, 2015

Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use

Feb. 02, 2015

Alcohol consumption when pregnancy is unwanted or unintended

Jan. 12, 2015

Latest Data on Contraceptive Use in the United States

Dec. 01, 2014

LateBreaker sampler from Contraceptive Technology conference

Nov. 05, 2014

Emergency Contraceptive Pill Efficacy and BMI/Body Weight

Sep. 29, 2014

Handout on Unintended Pregnancy and Contraceptive Choice

Aug. 27, 2014

Ask About Withdrawal (Really!)

Jul. 31, 2014

Rules to Practice By: Safety First and Cleanliness is Close to. . .

Jul. 01, 2014

What’s Vanity Fair Got Against the NuvaRing?

Jun. 02, 2014

Promising New Treatment for Hepatitis C

May. 01, 2014

Numbers matter, so make them simple for patients

Apr. 01, 2014

The Recession’s Effect on Unintended Pregnancies

Mar. 05, 2014

Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative

Feb. 03, 2014

Applying the “New” Cervical Cytology Guidelines in Your Practice

Jan. 02, 2014

Acute Excessive Uterine Bleeding: New Management Strategies

Dec. 03, 2013

Medical indications for IUD use in teens

Oct. 09, 2013

Whatever happened to PID?

Oct. 05, 2013

Update on Emergency Contraception